Advertisement
Case Report| Volume 79, P438.e1-438.e4, February 2022

Multiple Sites of Arterial Thrombosis in A 35-Year Old Patient after ChAdOx1 (AstraZeneca) Vaccination, Requiring Emergent Femoral and Carotid Surgical Thrombectomy

Published:October 10, 2021DOI:https://doi.org/10.1016/j.avsg.2021.07.033

      Abstract

      Background

      Vaccine Induced Thrombotic Thrombocytopenia (VITT) is a rare complication following ChAdOx1 (AstraZeneca) vaccination. Venous thrombosis in unusual sites such as splachnic or intracranial thrombosis, is the commonest manifestation.

      Case report

      We report a 35-year-old male patient who presented with acute left leg ischemia and thrombocytopenia 11-days after vaccination requiring emergent thrombectomy. During work-up, a localized thrombus was detected in the left carotid bifurcation mandating carotid thrombectomy. Localized right iliac thrombus causing a non-limiting flow stenosis was treated conservatively. The platelet aggregating capacity of patient's plasma was confirmed in a functional assay, thereby establishing VITT.

      Conclusion

      To the best of our knowledge this is the first case presenting multiple arterial thromboses requiring surgical treatment after ChAdOx1 vaccination.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Parums DV
        Editorial: SARS-CoV-2 mRNA vaccines and the possible mechanism of vaccine-induced immune thrombotic thrombocytopenia (VITT).
        Med SciMonit. 2021; 27e932899https://doi.org/10.12659/MSM.932899
        • Schultz NH
        • Sorvoll IH
        • Michelsen AE
        • et al.
        Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
        N Engl J Med. 2021; 384: 2124-2130https://doi.org/10.1056/NEJMoa2104882
        • Scully M
        • Singh D
        • Lown R
        • et al.
        Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination.
        N Engl J Med. 2021; 384: 2202-2211https://doi.org/10.1056/NEJMoa2105385
        • Greinacher A
        • Thiele T
        • Warkentin TE
        • et al.
        Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.
        N Engl J Med. 2021; https://doi.org/10.1056/NEJMoa2104840
        • Greinacher A
        • Selleng K
        • Warkentin TE
        Autoimmune heparin-induced thrombocytopenia.
        J ThrombHaemost. 2017; 15: 2099-2114
        • Cines DB
        • Bussel JB
        SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
        N Engl J Med. 2021; 384: 2254-2256https://doi.org/10.1056/NEJMe2106315
        • Greinacher A
        • Selleng K
        • Wesche J
        • et al.
        Towards understanding ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).
        ResSq. 2021; https://doi.org/10.21203/rs.3.rs-440461/v1
        • Franchini M
        • Liumbruno GM
        • Pezzo M
        COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome.
        Eur J Haematol. 2021; https://doi.org/10.1111/ejh.13665
        • Björck M
        • Earnshaw JJ
        • Acosta S
        • et al.
        Editor’s choice - european society for vascular surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia.
        Eur J VascEndovasc Surg. 2020; 59: 173-218https://doi.org/10.1016/j.ejvs.2019.09.006
      1. https://eae.gr/el/information/news/item/953-diagnostiki-kai-therapeftiki-prosegisi-asthenwn-me-syndromo-vipit-meta-emvoliasmo-me-astrazeneca-i-me-to-emvolio-ths-johnson-johnson. 2020. Accessed 30.05.2021

      2. https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia. 2020. Accessed 30.05.2021

      3. https://b-s-h.org.uk/media/19590/guidance-version-17-on-mngmt-of-vitt-20210420.pdf 2020. Accessed 30.05.2021

      4. https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-1469-7481.pdf. 2020. Accessed 30.05.2021

        • Galea V
        • Khaterchi Α
        • Robert F
        • et al.
        Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study.
        Platelets. 2013; 24: 441-447https://doi.org/10.3109/09537104.2012.724736
        • Tiede A
        • Sachs UJ
        • Czwalinna A
        • et al.
        Prothrombotic immune thrombocytopenia after COVID-19 vaccine.
        Blood. 2021; 1382021011958https://doi.org/10.1182/blood.2021011958
        • Jones M
        • Boisvert A
        • Landry J
        • et al.
        Limb ischemia and pulmonary artery thrombosis afer the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia.
        CMAJ. 2021; 193210795https://doi.org/10.1503/cmaj.210795